EZH2 and breast cancer: Second, in the breast cancer cell lines—MDA-MB-468, MDA-MB-231, and SKBr3—the MEK-ERK1/2 pathway activated EZH2 transcription via the direct recruitment of P-ELK1 on the EZH2 promoter.